Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
Vertos Medical said today it won national coverage for its Mild procedure designed to treat lumbar spinal stenosis from the Centers for Medicare & Medicaid Services.
The Mild procedure won coverage through a recently approved study as part of CMS’ Coverage with Evidence Development Program, the Aliso Viejo, Calif.-cased company said. Read more
Getinge‘s medical subsidiary Maquet Cardiovascular recently issued an urgent product recall notice for its Cardiosave intra-aortic balloon pump over issues with its lithium ion batteries sparking or smoking after being dropped.
In an urgent product recall notice, the company said it has received 3 reported occurrences of the batteries venting when dropped, creating the potential for smoke, foul odors and sparks. Read more
Johnson & Johnson subsidiary Ethicon is going ahead with the launch of its Enseal X1 instrument, despite an ongoing dispute with its longtime rival in the surgical cutting and sealing market, Medtronic subsidiary Covidien.
“Enseal X1 is the latest example of how Ethicon is advancing technology to give surgeons greater control, access, and accuracy during surgical procedures in an effort to improve outcomes for patients,” Ethicon chairman Michael del Prado said in prepared remarks. Read more
A trustee in the bankruptcy proceedings for Palmaz Scientific Inc. last week sued its co-founders and members of its board, alleging that they looted the company before declaring bankruptcy last year.
Co-founded by coronary stent pioneer Dr. Julio Palmaz and CEO Steven Solomon in 2008 to commercialize Palmaz’s ideas, PSI raised about $40 million before pulling the plug in a year ago. Read more
A plan to repeal and replace the Affordable Care Act floated by Republicans yesterday – which critics have already dubbed “Trumpcare” or “Obamacare Lite” – would permanently repeal the medical device tax effective Jan. 1, 2018.
A hold on the 2.3% tax on U.S. medical device sales went into effect at the beginning of 2016 and is slated to expire by the end of this year. The legislative plan released last night by GOP members of the U.S. House of Representatives would kill the tax for good effective Jan. 1, 2018. Read more